Daniel Indiviglio: It's not just banks that like OTC derivatives, a notion debunked by WSJ as...

|By:, SA News Editor
Daniel Indiviglio: It's not just banks that like OTC derivatives, a notion debunked by WSJ as they point out lots of companies are pushing back on regulations that "will [surprise!] increase companies' costs." Forty-three nonfinance companies were lobbying the issue just in Q1, vs. 22 in the past four years combined. (earlier)